Home >> Research Area >>GPCR/G protein>>Chemokine Receptors>> BX 513 hydrochloride

BX 513 hydrochloride

Selective CCR1 antagonist CAS# 1216540-18-9

BX 513 hydrochloride

Catalog No. BCC5940----Order now to get a substantial discount!

Product Name & Size Price Stock
BX 513 hydrochloride: 5mg $127 In Stock
BX 513 hydrochloride: 10mg Please Inquire In Stock
BX 513 hydrochloride: 20mg Please Inquire Please Inquire
BX 513 hydrochloride: 50mg Please Inquire Please Inquire
BX 513 hydrochloride: 100mg Please Inquire Please Inquire
BX 513 hydrochloride: 200mg Please Inquire Please Inquire
BX 513 hydrochloride: 500mg Please Inquire Please Inquire
BX 513 hydrochloride: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of BX 513 hydrochloride

Number of papers citing our products

Chemical structure

BX 513 hydrochloride

3D structure

Chemical Properties of BX 513 hydrochloride

Cas No. 1216540-18-9 SDF Download SDF
PubChem ID 56972186 Appearance Powder
Formula C28H30Cl2N2O M.Wt 481.46
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in DMSO > 10 mM
Chemical Name 5-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-2,2-diphenylpentanenitrile;hydrochloride
SMILES C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4.Cl
Standard InChIKey SSZWNUGWOGONQJ-UHFFFAOYSA-N
Standard InChI InChI=1S/C28H29ClN2O.ClH/c29-26-14-12-25(13-15-26)28(32)17-20-31(21-18-28)19-7-16-27(22-30,23-8-3-1-4-9-23)24-10-5-2-6-11-24;/h1-6,8-15,32H,7,16-21H2;1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of BX 513 hydrochloride

DescriptionSelective CCR1 receptor antagonist (Ki values are 0.04, > 10, > 10 and > 10 nM for CCR1, CCR5, CXCR2 and CXCR4 receptors respectively). Inhibits MIP-1α-induced intracellular calcium mobilization (IC50 = 2.5 μM). Also a full inverse agonist at US28, a HCMV-encoded chemokine receptor.

BX 513 hydrochloride Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

BX 513 hydrochloride Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of BX 513 hydrochloride

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.077 mL 10.3851 mL 20.7702 mL 41.5403 mL 51.9254 mL
5 mM 0.4154 mL 2.077 mL 4.154 mL 8.3081 mL 10.3851 mL
10 mM 0.2077 mL 1.0385 mL 2.077 mL 4.154 mL 5.1925 mL
50 mM 0.0415 mL 0.2077 mL 0.4154 mL 0.8308 mL 1.0385 mL
100 mM 0.0208 mL 0.1039 mL 0.2077 mL 0.4154 mL 0.5193 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on BX 513 hydrochloride

Ligands for the CCR1 receptor (MIP-1α and RANTES) have been implicated in plenty of chronic inflammatory diseases, most notably multiple sclerosis and rheumatoid arthritis. BX 513 is a novel non-peptide CCR1 receptor antagonists.

In vitro: BX 513 has been shown to have at least 200-fold selectivity for CCR1 inhibition over other human 7-TM receptors, including other chemokine receptors. In addition, data obtained from in-vitro functional assays demonstrated the functional antagonism of BX 513 and structurally related analogues against the CCR1 receptor in a dose-dependent manner [1]. BX 513 also showed concentration-dependent inhibition of MIP-1α-induced extracellular acidification and Ca2+ mobilization demonstrating functional antagonism. When given alone, the compound did not elicit any responses, suggesting the absence of intrinsic agonist activity. BX 513 inhibited MIP-1α- and RANTES-induced migration in peripheral blood cells in a dose-responsive manner. Selectivity testing against a panel of 7 transmembrane domain receptors indicated that BX 513 is inactive on a number of receptors at concentrations up to 10 μM [2].

In vivo: Currently, there is no animal in-vivo data available.

Clinical trial: Up to now, BX 513 is still in the preclinical development stage.

Reference:
[1] Ng HP, May K, Bauman JG, Ghannam A, Islam I, Liang M, Horuk R, Hesselgesser J, Snider RM, Perez HD, Morrissey MM.  Discovery of novel non-peptide CCR1 receptor antagonists. J Med Chem. 1999 Nov 4;42(22):4680-94.
[2] Hesselgesser J, Ng HP, Liang M, Zheng W, May K, Bauman JG, Monahan S, Islam I, Wei GP, Ghannam A, Taub DD, Rosser M, Snider RM, Morrissey MM,Perez HD, Horuk R.  Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J Biol Chem. 1998 Jun 19;273(25):15687-92.

Featured Products
New Products
 

Keywords:

BX 513 hydrochloride,1216540-18-9,Natural Products,Chemokine Receptors, buy BX 513 hydrochloride , BX 513 hydrochloride supplier , purchase BX 513 hydrochloride , BX 513 hydrochloride cost , BX 513 hydrochloride manufacturer , order BX 513 hydrochloride , high purity BX 513 hydrochloride

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: